THE IMPROVING RENAL OUTCOMES COLLABORATIVE (EIN 850840241) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2020

Legal Domicile

Principal Officer

LINDSEY DEMAINTENON

Phone

5134003137

Tax Period

2024-07-01 to 2025-06-30

THE IMPROVING RENAL OUTCOMES COLLABORATIVE, founded in 2020, is a small nonprofit in the Diseases & Disorders sector that reported $852K in total revenue in fiscal year 2024. Revenue decreased 12% compared to the prior year. Expenses of $772K left a modest 9% surplus.

Mission

PARTNER WITH PATIENTS WITH A KIDNEY TRANSPLANT AND THEIR FAMILIES TO IMPROVE HEALTH, LONGEVITY, AND QUALITY OF LIFE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $852,287

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $852,287

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $772,055

Other Expenses $772,055

TOTAL EXPENSES $772,055

Year-over-Year Comparison

	2024	2023	Change
Revenue	$852,287	$972,869	-0.1%
Expenses	$772,055	$1,053,462	-0.3%
Net Income	$80,232	$-80,593	-2.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
PETER MARGOLIS	TRUSTEE	1.00	Director	$0	$0	$0
GINA BARLETTA	TRUSTEE	1.00	Director	$0	$0	$0
ROB LESAN	TRUSTEE	1.00	Director	$0	$0	$0
KEVIN FOWLER	TRUSTEE	1.00	Director	$0	$0	$0
ABANTI CHAUDHURI	TRUSTEE	1.00	Director	$0	$0	$0
DEREK STREAT	CO-FOUNDER	1.00	Officer	$0	$0	$0
JENS GOEBEL	BOARD PRESIDENT	1.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$852,287	$772,055	$168,911	$80,232
2024	$972,869	$1,053,462	$88,679	$-80,593
2023	$503,800	$518,122	$169,272	$-14,322
2022	$808,190	$922,644	$183,594	$-114,454

THE IMPROVING RENAL OUTCOMES COLLABORATIVE